NURUN BEGUM: Open Payments
NPI 1467024828 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 10 payments from 5 companies in 2025. Trend: 2023 $105 · 2024 $619 · 2025 $482
Food & beverage: $482
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $162 |
| AstraZeneca Pharmaceuticals LP | 1 | $120 |
| ABBVIE INC. | 1 | $117 |
| Merck Sharp & Dohme LLC | 3 | $68 |
| PFIZER INC. | 1 | $14 |
Products named: CAMZYOS, FARXIGA, LINZESS, VERQUVO, CAPVAXIVE, VYNDAQEL.
Industry payments across NY — which companies pay providers there.
